Search

Your search keyword '"Khalid S. Mohammad"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Khalid S. Mohammad" Remove constraint Author: "Khalid S. Mohammad" Language english Remove constraint Language: english
43 results on '"Khalid S. Mohammad"'

Search Results

2. Intersecting Paths: Unraveling the Complex Journey of Cancer to Bone Metastasis

3. Aging‐associated skeletal muscle defects in HER2/Neu transgenic mammary tumour model

4. TG-interacting factor 1 (Tgif1)-deficiency attenuates bone remodeling and blunts the anabolic response to parathyroid hormone

5. Translational Strategies to Target Metastatic Bone Disease

6. Tip110/SART3 regulates IL-8 expression and predicts the clinical outcomes in melanoma

7. The Role of TGF-β in Bone Metastases

8. Osteocyte-Intrinsic TGF-β Signaling Regulates Bone Quality through Perilacunar/Canalicular Remodeling

9. Loss of Asxl1 Alters Self-Renewal and Cell Fate of Bone Marrow Stromal Cells, Leading to Bohring-Opitz-like Syndrome in Mice

10. Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model

11. Comparison of electric motors used in electric vehicle propulsion system

12. Increased S1P expression in osteoclasts enhances bone formation in an animal model of Paget's disease

13. Aging-associated skeletal muscle defects in HER2/Neu transgenic mammary tumor model

14. Halofuginone inhibits TGF-β/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis

15. Mechanical Suppression of Breast Cancer Cell Invasion and Paracrine Signaling Requires Nucleo-Cytoskeletal Connectivity

16. Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo

17. Loss of Asxl1 Alters Self-Renewal and Cell Fate of Bone Marrow Stromal Cell, Leading to Bohring-Opitz-like Syndrome in Mice

18. Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis

19. Osteolytic Breast Cancer Causes Skeletal Muscle Weakness in an Immunocompetent Syngeneic Mouse Model

20. Bone-induced expression of integrin β3 enables targeted nanotherapy of breast cancer metastases

21. Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis

22. Regulation of Postnatal Trabecular Bone Formation by the Osteoblast Endothelin A Receptor

23. TGFβ-Mediated induction of SphK1 as a potential determinant in human MDA-MB-231 breast cancer cell bone metastasis

24. Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin

25. Dystrophic spinal deformities in a neurofibromatosis type 1 murine model

26. Generation of the first Autosomal Dominant Osteopetrosis Type II (ADO2) disease models

27. RANKL/RANK/MMP-1 molecular triad contributes to the metastatic phenotype of breast and prostate cancer cells in vitro

28. Decreased autocrine EGFR signaling in metastatic breast cancer cells inhibits tumor growth in bone and mammary fat pad

29. c-Fms signaling mediates neurofibromatosis Type-1 osteoclast gain-in-functions

30. The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1

31. Hypoxia and TGF-β Drive Breast Cancer Bone Metastases through Parallel Signaling Pathways in Tumor Cells and the Bone Microenvironment

32. DICKKOPF HOMOLOG 1 MEDIATES ENDOTHELIN-1-STIMULATED NEW BONE FORMATION*

33. IMPROVING COMPATIBILITY OF RECYCLED NITRILE RUBBER (rNBR) AND ETHYLENE VINYL ACETATE (EVA) BLENDS BY ELECTRON BEAM IRRADIATION.

34. The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone

35. Tumor-expressed adrenomedullin accelerates breast cancer bone metastasis

36. Growth factor independence 1 expression in myeloma cells enhances their growth, survival, and osteoclastogenesis

37. Dystrophic spinal deformities in a neurofibromatosis type 1 murine model.

38. RANKL/RANK/MMP-1 molecular triad contributes to the metastatic phenotype of breast and prostate cancer cells in vitro.

39. Decreased autocrine EGFR signaling in metastatic breast cancer cells inhibits tumor growth in bone and mammary fat pad.

40. c-Fms signaling mediates neurofibromatosis Type-1 osteoclast gain-in-functions.

41. The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1.

42. Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment.

43. Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone.

Catalog

Books, media, physical & digital resources